EXOZYMES INC. Income Statement
EXOZ|1 years of annual SEC 10-K data (FY2024-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
EXOZYMES INC. reported $70,069 in revenue and $2M in net loss for FY2024. Its profit margin was -2909.1% in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 |
|---|---|
| Revenue | $70.1K |
| SG&A Expense | $1.3M |
| R&D Expense | $527.5K |
| Operating Income | -$1.8M |
| Income Tax | $42.3K |
| Net Income | -$2.0M |
| EPS (Basic) | -$0.33 |
| EPS (Diluted) | -$0.33 |
| Shares Outstanding | 6.3M |
| Operating Margin | -2563.5% |
| Profit Margin | -2909.1% |